Contrast Media

Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.

FDA approves Bayer’s Ultravist (iopromide) Injection for Contrast-enhanced Mammography
June 26, 2023 — Bayer announced that Ultravist…
VIDEO: Talking Trends with Bracco: Investing in the Future of Radiology
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research, development, and manufacture of…
Bayer Announces Acquisition of Blackford Analysis to Advance AI in Radiology Imaging
January 18, 2023 — Addressing the growing demand for medical imaging and a shortage of radiologists,
At RSNA, Bayer to Showcase Product Offerings and Announces Broadened AI Offering in Radiology
November 26, 2022 — As international leaders in the field of Imaging gather for the 2022 Radiological Society of North America (RSNA) Annual Meeting, Bayer Radiology, a leader in diagnostic imaging, will showcase its portfolio of products and solutions intended to address today's most pressing…
Guerbet Announces FDA Approval of Elucirem (Gadopiclenol) for Use in Contrast-enhanced MRI
September 21, 2022 – Guerbet, a global medical imaging company, has announced that the U.S.

Leaders in radiology will share insights on VUEWAY (gadopiclenol) solution for injection after the first year of use in the US

News | Contrast Media

Bracco Diagnostics Showcases Innovation and Collaborative Vision at RSNA 2023 Annual Meeting

November 13, 2023 — Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a pioneer in diagnostic ...

November 13, 2023

ELUCIRE (gadopiclenol) Injection Safety Data Poster Presentation

News | Interventional Radiology

Guerbet to Spotlight Diagnostic and Interventional Solutions at the 2023 Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting

November 3, 2023 — Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced ...

November 03, 2023

Halo tapped to support Bayer’s phase III clinical development program, QUANTI

News | Magnetic Resonance Imaging (MRI)

Halo Precision Diagnostics Collaborating with Bayer to Advance Contrast-Enhanced MRI

October 17, 2023 — Halo Precision Diagnostics, a leader in early disease detection using precision diagnostics, today ...

October 17, 2023

Sponsored Content

Videos | Contrast Media

VIDEO: Talking Trends with Bracco: Investing in the Future of Radiology

Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...

February 27, 2023

Imaging Biometrics, LLC announced the results of a study that validates IB Neuro’s processing of reduced-dose gadolinium-based contrast agent (GBCA) perfusion studies on 1.5T scanners

News | Contrast Media

Reduced Gadolinium Approach Validated with IB Neuro on 1.5T MR Scanners

September 21, 2023 — Imaging Biometrics, LLC announced the results of a study that validates IB Neuro’s processing of ...

September 21, 2023

Contrast enhanced ultrasound (CEUS) is underutilized in the United States

News | Ultrasound Imaging

CEUS Underutilization May Pose Greater Risk Than Rare Side Effects Associated With Use, Say Experts

September 15, 2023 — Contrast enhanced ultrasound (CEUS) is underutilized in the United States, and reduced access to ...

September 15, 2023

Study investigated impact of radiographic media contrast shortage on stroke patient scan data

News | Contrast Media

Researchers Discover Contrast Dye Shortage Affected Assessment of Stroke Patients

August 17, 2023 — University of Missouri School of Medicine neurologist Adnan Qureshi, MD recently led a study that ...

August 17, 2023

Sponsored Content

Case Study | SPECT-CT

Making the Invisible Visible: Spectral CT 7500 Transforms Patient Care with

A patient’s chance of recovery can be directly impacted when a diagnosis is missed or delayed. To get the right ...

July 06, 2022

FDA-approved generic for MRI procedures is fully substitutable for Gadavist

News | Contrast Media

Fresenius Kabi Further Expands Radiology Portfolio with Launch of Gadobutrol Injection

August 8, 2023 — Fresenius Kabi announced it has launched Gadobutrol Injection, a generic substitute for the contrast ...

August 08, 2023

FDA-approved in May 2023, POSLUMA is commercially available through 36 radiopharmacies across the United States

News | Prostate Cancer

Blue Earth Diagnostics Announces Addition of POSLUMA (Flotufolastat F 18) Injection to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer

July 28, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

July 28, 2023

Scientists have found a new use for copper in magnetic resonance imaging (MRI) contrast agent design, that could help to create better images which help doctors diagnose patients’ conditions more easily and safely.

News | Magnetic Resonance Imaging (MRI)

Copper Could Help Create Clearer MRI Images and Improved Diagnosis

July 27, 2023 — Scientists have found a new use for copper in magnetic resonance imaging (MRI) contrast agent design ...

July 27, 2023

Sponsored Content

Lawrence N. Tanenbaum, MD FACR is Vice President/Chief Technology Officer Director of CT, MR, and Advanced Imaging for RadNet with 37+ years experience in the medical field. He is a member of editorial boards of several journals/educational organizations and reviewer for scientific journals. He has authored 100+ scholarly and peer-reviewed articles, chairs educational/academic meetings, and has delivered 2000+ invited global lectures.

Case Study | Contrast Media Injectors

Case Studies with Lawrence N. Tanenbaum, MD FACR Using Macrocyclic CLARISCAN

Product Indications and Use: CLARISCAN (gadoterate meglumine) is a gadolinium-based contrast agent indicated for ...

May 03, 2022

News | Contrast Media

Bracco Imaging Announces Publication of Data Reinforcing Efficacy, Safety of Gadopiclenol in Contrast-Enhanced MRI of Certain Body Regions

July 25, 2023 — Bracco Imaging has issued a statement on new results published in the journal Radiology which found that ...

July 25, 2023

Comprehensive clinical development program called QUANTI includes two Phase III studies in adults and one pediatric study investigating gadoquatrane for use in MRI across all body regions and across ages from birth to adulthood

News | Contrast Media

Bayer initiates Phase III Studies with Investigational Contrast Agent Gadoquatrane

July 7, 2023 — Bayer, a global leader in radiology, has initiated the Phase III clinical development program called ...

July 06, 2023

Preferential use of pulmonary MR angiography (MRA) for diagnosing pulmonary embolus (PE) in the general population helped conserve iodinated contrast media during the 2022 shortage

News | Contrast Media

Switch to MR Angiography for PE Mitigated Impact of Recent Contrast Shortage

July 3, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

July 03, 2023

Sponsored Content

Videos | Contrast Media

Talking Trends with GE Healthcare: Ensuring a Secure and Sustainable Supply

With the use of contrast agents and radiotracers on the rise, GE Healthcare has seen increases in demand across their ...

February 23, 2022

Contrast-enhanced mammography (CEM) is an emerging modality combining digital mammography with the administration of a contrast agent

News | Contrast Media

FDA approves Bayer’s Ultravist (iopromide) Injection for Contrast-enhanced Mammography

June 26, 2023 — Bayer announced that Ultravist (iopromide)-300, -370, its iodine-based contrast agent, has been approved ...

June 26, 2023

Therapeutically equivalent and fully substitutable to Kinevac (Sincalide for Injection) formulated, filled and packaged in the United States provides health care facilities with choice and value

News | Contrast Media

Fresenius Kabi Broadens Radiology Portfolio with its First-to-Market Authorized Generic, Sincalide for Injection

June 21, 2023 — Fresenius Kabi, a leading provider of injectable medicines, announced today it has launched the ...

June 21, 2023

News | Contrast Media

MRI Contrast Agent Orviglance Hepatic Impairment Data Presented by Ascelia Pharma at ESGAR 2023

June 20, 2023 — Ascelia Pharma presented data from its Orviglance Hepatic Impairment study during the European Society ...

June 20, 2023

VUEWAY (gadopiclenol) solution for injection and VUEWAY (gadopiclenol) Pharmacy Bulk Package are available for use in the U.S. following the market launch in February 20231

News | Contrast Media

American College of Radiology Classifies VUEWAY as a Group II Agent Relative to NSF

May 16, 2023 — Bracco Imaging, an innovative world leader delivering end-to-end products and solutions through a ...

May 16, 2023

Elucirem, a novel new macrocyclic GBCA for use in contrast-enhanced magnetic resonance imaging (MRI), has the highest relaxivity compared to other non-specific GBCAs (gadolinium-based contrast agents)

News | Contrast Media

Guerbet Announces ACR Committee on Drugs and Contrast Media Classifies Elucirem (Gadopiclenol) Injection a Group II Agent

May 15, 2023 — Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced that ...

May 15, 2023

In the past year, the radiology community has been a first-hand, hands-on witness to myriad unexpected challenges and unprecedented partnerships emerging on the scene of the contrast media market

Feature | Contrast Media | By Christine Book

A Look Inside the Contrast Media Market

In the past year, the radiology community has been a first-hand, hands-on witness to myriad unexpected challenges and ...

May 03, 2023

At the urging of the American College of Radiology (ACR) and others, the US Food and Drug Administration will now recommend thyroid monitoring only for high-risk young children who receive intravascular iodine-containing contrast media for thyroid dysfunction

News | Pediatric Imaging

ACR-Backed FDA Action to Monitor Young At-Risk Children Who Receive Iodinated Contrast Media

April 28, 2023 — At the urging of the American College of Radiology (ACR) and others, the US Food and Drug ...

April 28, 2023

News | PET Imaging

Nuclidium and University Hospital Basel Receive NETRF Investigator Award to Initiate Phase 1 Trial with Novel Copper-based Radiotheranostic Program TraceNET in Neuroendocrine Tumors

March 23, 2023 — Nuclidium announced that the Neuroendocrine Tumors Research Foundation (NETRF) has selected the company ...

March 24, 2023